Teladoc Health SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 4:04 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedTeladoc Health Q3 2026 revenue of $605.1 million beats $590.5 million consensus and EPS of -$0.15 beats -$0.19, but FY2026 EPS guidance midpoint of -$0.85 trails -$0.79 consensus
8-KSept. 25, 2026, 8:30 a.m. ETView on SEC.gov
Departure/appointment of directors or officers
8-KAug. 31, 2026, 4:35 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 13, 2026, 4:05 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
8-KAug. 3, 2026, 4:31 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KJuly 29, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits